Trademark: 76568022
Word
CG CHONDROGENE
Status Date
Friday, February 26, 2016
Registration Number
3656206
Registration Date
Tuesday, July 21, 2009
Filing Date
Wednesday, December 31, 2003
Published for Opposition
Tuesday, October 7, 2008
Cancellation Date
Friday, February 26, 2016
1 (Based on Use in Commerce) (Based on 44(e)) Diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for medical research and development use; (Based on on 44(e)) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for research use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for research use
5 (Based on 44(e)) Diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, proteins and antibodies, and molecular arrays of biological material for medical laboratory use; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for clinical or medical use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for clinical or medical use; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies, and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use
42 (Based on Use in Commerce) (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics; (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of pharmacogenomics, toxicogenomics and personalized medicine; Evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research
44 (Based on 44(e)) Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors
Color is not claimed as a feature of the mark.
Feb 26, 2016
Cancelled Sec. 8 (6-Yr)
Jul 21, 2009
Registered-Principal Register
Jun 17, 2009
1(B) Basis Deleted; Proceed To Registration
Jun 16, 2009
Notice Of Allowance Cancelled
Jun 17, 2009
Case Assigned To Intent To Use Paralegal
Jun 16, 2009
Teas Delete 1(B) Basis Received
Dec 30, 2008
Noa Mailed - Sou Required From Applicant
Oct 7, 2008
Published For Opposition
Sep 17, 2008
Notice Of Publication
Sep 4, 2008
Law Office Publication Review Completed
Aug 28, 2008
Approved For Pub - Principal Register
Aug 28, 2008
Examiners Amendment Mailed
Aug 27, 2008
Examiner's Amendment Entered
Aug 27, 2008
Examiners Amendment -Written
Aug 14, 2008
Teas/Email Correspondence Entered
Aug 13, 2008
Correspondence Received In Law Office
Aug 13, 2008
Teas Response To Office Action Received
Jun 18, 2008
Non-Final Action Mailed
Jun 17, 2008
Non-Final Action Written
May 5, 2008
Previous Allowance Count Withdrawn
Apr 28, 2008
Withdrawn From Pub - Og Review Query
Apr 11, 2008
Law Office Publication Review Completed
Apr 10, 2008
Approved For Pub - Principal Register
Apr 8, 2008
Teas/Email Correspondence Entered
Apr 8, 2008
Correspondence Received In Law Office
Apr 8, 2008
Teas Response To Office Action Received
Nov 9, 2007
Non-Final Action Mailed
Nov 8, 2007
Non-Final Action Written
Oct 18, 2007
Previous Allowance Count Withdrawn
Oct 5, 2007
Withdrawn From Pub - Og Review Query
Sep 21, 2007
Law Office Publication Review Completed
Sep 20, 2007
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 20, 2007
Teas Change Of Owner Address Received
Sep 19, 2007
Approved For Pub - Principal Register
Sep 12, 2007
Amendment From Applicant Entered
Sep 12, 2007
Correspondence Received In Law Office
Aug 22, 2007
Automatic Update Of Assignment Of Ownership
Aug 6, 2007
Paper Received
Mar 29, 2007
Priority Action Mailed
Mar 28, 2007
Priority Action Written
Feb 12, 2007
Previous Allowance Count Withdrawn
Feb 5, 2007
Withdrawn From Pub - Og Review Query
Jan 14, 2007
Law Office Publication Review Completed
Jan 12, 2007
Approved For Pub - Principal Register
Jan 12, 2007
Amendment From Applicant Entered
Jan 12, 2007
Correspondence Received In Law Office
Jan 12, 2007
Assigned To Lie
Dec 11, 2006
Paper Received
Oct 23, 2006
Letter Of Suspension Mailed
Oct 20, 2006
Suspension Letter Written
Oct 13, 2006
Amendment From Applicant Entered
Sep 5, 2006
Correspondence Received In Law Office
Sep 5, 2006
Paper Received
Jun 20, 2006
Attorney Revoked And/Or Appointed
Jun 20, 2006
Teas Revoke/Appoint Attorney Received
Mar 13, 2006
Inquiry As To Suspension Mailed
Mar 12, 2006
Suspension Inquiry Written
Sep 12, 2005
Letter Of Suspension Mailed
Sep 9, 2005
Suspension Letter Written
Sep 9, 2005
Amendment From Applicant Entered
Aug 16, 2005
Correspondence Received In Law Office
Aug 16, 2005
Paper Received
Mar 23, 2005
Letter Of Suspension Mailed
Mar 23, 2005
Suspension Letter Written
Mar 23, 2005
Examiners Amendment -Written
Mar 14, 2005
Letter Of Suspension Mailed
Mar 13, 2005
Suspension Letter Written
Feb 23, 2005
Amendment From Applicant Entered
Jan 31, 2005
Correspondence Received In Law Office
Jan 31, 2005
Paper Received
Aug 2, 2004
Non-Final Action Mailed
Jul 20, 2004
Assigned To Examiner
Jan 14, 2004
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
